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Abstract
Objective Toll-like receptor 4 (TLR-4) is a transmembrane protein involved in the innate immune system and
has been implicated in the pathogenesis of temporomandibular joint dysfunction (TMD). The purpose of this
study was to histologically examine the level of expression of TLR-4 relative to severity of TMD.

Methods Thirty-one human TMJ disc samples were immunostained for TLR-4 and evaluated for intensity of
stain. Among the samples, 8 were control samples, 16 were from patients with anterior disc displacement with
reduction (ADDwR), and 7 were from patients with anterior disc displacement without reduction (ADDwoR).

Results There was no statistically significant difference in intensity of stain between groupings (p = 0.673).
Conclusions The results indicate a negative correlation between TMD and the expression of TLR-4.
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Introduction
The temporomandibular joint (TMJ) is subjected to constant destructive forces through function, which is paired
with the body’s ability to adapt [1]. The TMJ dysfunction (TMD) disease process, which commonly initiates
during puberty, has several associated risk factors, such as female sex, hypermobility, and trauma [2]. In the
healthy joint, the disc rests between the condylar head of the mandible and the articular surface of the temporal
bone [3]. Following the onset of joint dysfunction, the temporomandibular disc undergoes structural changes,
which may result in an anterior disc displacement, which may reduce to a normal functional position or not [4].
This first stage of TMD is called anterior disc displacement with reduction (ADDwR), and in more advanced
cases, the disc remains anteriorly displaced throughout function, never reducing into proper physiological
position, known as anterior disc displacement without reduction (ADDwoR) [4].
Functional stresses on the TMJ activate a continuous process of extracellular matrix degradation and synthesis
[1]; nevertheless, if functional demands exceed the ability to adapt, an inflammatory process is initiated, and a
cartilaginous breakdown occurs [5]. Although the exact biochemical mechanism by which this breakdown occurs
is yet to be understood, several theories exist [6–9]. There is an established linkage between the degree of TMJ
dysfunction and the level of inflammation, which presents as an upregulation of proinflammatory cytokines IL1(beta) and TNF-(alpha) [10–14]. This linkage has also been shown in patients with TMD resulting from
rheumatoid arthritis. However, in these cases, TNF-α was found to correlate to the level of condylar erosion
[15].
Similarly, toll-like receptor 4 (TLR-4) is understood to participate in inflammatory processes. TLR-4 is a
transmembrane protein responsible for activation of the MyD88-dependent inflammatory pathway, ultimately
resulting in upregulation of proinflammatory mediators such as TNF-alpha and IL-1beta. Recent publications
have re-evaluated TLR-4 for its potential role in the pathogenesis of TMJ pathologies [16,17]. Only recently has
TLR-4 been implicated in identification of danger-associated molecular patterns (DAMPs). DAMPS are

endogenous signals suggesting cellular distress, even in the absence of certain exogenous materials. Several of
these ligands have been shown to exert their effects on TLR-4 even in the absence of lipopolysaccharide (LPS),
its most well-known ligand [17]. This would indicate a true agonist role, and not just as an assistant to LPS. TLR-4
has been extensively studied and associated with rheumatoid arthritis patients’ joints; however, there is no
study of how this protein acts on joints with dysfunction but with no rheumatoid arthritis.
Thus, the purpose of this study was to investigate the role of TLR-4 in the pathogenesis of TMD.

Materials and methods
A total of 31 disc samples were collected from Caucasian female patients treated between 2002 and 2009 at the
Hospital Universitario Evangelico de Curitiba (Table 1).
Table 1. Clinical data of patients reported.
Patient Age (yrs) Diagnosis Affected side
Right
1
33
ADDwR
×
2
26
ADDwR
×
3
26
ADDwR
4
30
ADDwR
5
25
ADDwR
6
25
ADDwR
×
7
37
ADDwR
×
8
37
ADDwR
9
20
ADDwR
10
36
ADDwR
×
11
36
ADDwR
12
38
ADDwR
×
13
38
ADDwR
14
22
ADDwR
×
15
22
ADDwR
16
34
ADDwR
17
23
ADDwoR
18
23
ADDwoR ×
19
26
ADDwoR
20
32
ADDwoR
21
32
ADDwoR ×
22
35
ADDwoR ×
23
24
ADDwoR
24
27
CF×
25
33
CF×
×
26
42
CF×
×
27
18
CF×
28
43
CH
29
17
CH
30
18
CH
×
31
40
CH

Left

×
×
×

×
×
×
×
×
×
×
×
×

×
×

×
×
×
×

Notes: YRS: years; ADDWOR: Anterior disc displacement without reduction; ADDWR: anterior disc displacement with
reduction; CH: condylar hyperplasia; CF×: condylar fracture.

Eight virtually unaffected human discs were included in the control group for the study. Exclusion criteria for the
subjects included: use of orthodontic appliances; chronic usage of anti-inflammatory drugs; history of diabetes,
hepatitis, or HIV infection; immunosuppressive chemotherapy; history of any disease known to severely
compromise immune function; current pregnancy or lactation; dentofacial deformity; comorbidities of the TMJ;
pain related to muscular spasms alone; major jaw trauma previously; previous TMJ surgery; or previous steroid
injection in the TMJ. The subjects completed personal medical history questionnaires and, within a protocol
approved by an Institutional Review Board, signed a consent form after being advised of the nature of the study.
All patients were asked to complete a pain questionnaire, and an experienced oral and maxillofacial surgeon
performed a clinical examination. The clinical examination included palpation of the TMJ region, noting the
occurrence of painful opening/closing of the mouth, and listening for crepitation. The patients considered to be
affected were treated surgically when they presented painful clinical signs of disc displacement after
unsuccessful non-surgical treatment for at least six months. For the complementary exams, all patients received
a panoramic radiograph and MRI imaging studies. The subjects were included in clinical categories according to
the presence or absence of disc displacement. The test group included a total of 23 samples of discs that were
diagnosed with TMJ dysfunctions. This group was separated into ADDwR (n = 16) and ADDwoR (n = 7). The
control group included a total of eight samples. The discs of these patients were removed for reasons other than
TMJ dysfunction. Four of the patients presented with condyle fractures that were confirmed by radiographs and
CT scans. These subjects were included, provided that no trauma had occurred prior to the event causing the
condylar fracture and that the surgery was conducted up to 24 h after the trauma. Four other control samples
were obtained from patients who displayed active condylar hyperplasia. Wedges of the control discs were
removed from the posterior regions so that the disc could physiologically adapt to the head of the condyle
during function.

Staining protocol
Sample slides were deparaffinized with a series of nine solvent baths in Coplin jars, each lasting for 5 min. The
baths consisted of 100% xylene three times, 100% ethanol twice, 95% ethanol and 5% deionized water twice,
and 100% deionized water twice.
In order to unmask all potential antigens, a 10 mM sodium citrate buffer was prepared and kept at a sub-boiling
temperature until use. Samples were bathed in this buffer for a total of 40 min and were removed from the heat
source to cool after 20 min.
To increase specificity, samples were sequentially exposed to a peroxidase suppressor, followed by a 5% bovine
serum albumin (BSA) blocking buffer in phosphate buffered saline (PBS) for 30 min each.
Samples were incubated with TLR-4 primary antibody (Thermo Fisher Scientific, Rockford, IL, USA) for 30 min at
23°C. A 1:200 dilution of primary antibodies was synthesized from stock antibody and PBS. Biotinylated
secondary antibodies were then incubated on samples under the same conditions for 30 min, with a dilution of
1:400 with PBS. Avidin-Biotin Complex (ABC) was generated according to manufacturer specifications and
applied to samples following secondary antibody application, in order to amplify available signal. ABC incubation
lasted for 30 min. Finally, a 1:9 dilution of 10 × 3.3′-diaminobenzidine (DAB) chromogen concentrate was
prepared immediately before use and exposed to samples for exactly five min. Between each step in the staining
protocol, samples were washed twice with PBS for five min each.

Slides were dehydrated by following the deparaffinization solvent bath process in reverse, with each bath lasting
for 15 s.

Evaluation protocol
TLR-4 staining was identified as either positive or negative for each disc. Positive staining was defined as the
presence of brown chromogen detection, distributed within the cytoplasm or in the immediate
lacunar/pericellular space. Three blinded observers evaluated the percentage of immunopositive cells. The
observers scored the percentages based on a predetermined scale (0 ≤ 5%; 1 = 6–30%; 2 = 31–50%, 3 = 51–75%;
4 = 76–100%). Counting was performed at 200 × and 400 × magnification. The intensity of the staining was also
categorized on a four-point predetermined scale (0 = no detectable staining, 1 = light staining, 2 = moderate
staining, 3 = strong staining, and 4 = very strong staining). If the observers’ grading disagreed by more than one
point, the field of view that was being graded was thrown out and a new field of view was chosen. For each disc,
five areas were analyzed for both percentage and intensity of staining.

Statistical analysis
Stata/SE v.14.1. StataCorpLP, USA was used for the statistical analyses. Area and density were analyzed through
media, median, standard deviation, minimum and maximum, and to evaluate the intensity normality, ShapiroWilk was used. The comparison of the three groups employed the non-parametric Kruskal-Wallis test. A value
of p < 0.05 indicated a statistical difference.

Results
The presence of TLR-4 was confirmed through a specific immunohistochemical protocol. Background staining or
noise was reduced to a minimum, with positive staining existing exclusively on fibroblasts with TLR-4 expression.
Prevalence of staining for each sample was subjectively assessed, and values were used in a one-way ANOVA
statistical analysis. A positive but non-significant trend in mean TLR-4 expression was seen between the control
(Figure 1), ADDwR (Figure 2), and ADDwoR (Figure 3). The authors did not reach a statistically significant level for
any pairings (p = 0.673). Intensity of staining for each sample is displayed in Table 2 and Figure 4.
Figure 1. Control group.

Figure 2. Anterior disc displacement with reduction.

Figure 3. Anterior disc displacement without reduction.

Table 2. Intensity of fibroblast staining.
Group
Control
ADDwR
ADDwoR

n
8
16
7

Mean
2.08
2.29
2.38

Median
2.00
2.00
1.67

Minimum
1.000
1.000
1.000

Maximum
2.00
2.00
1.67

Standard deviation p value*
2.00
0.673
2.00
1.67

Notes: n: number; ADDwR: anterior disc displacement with reduction; ADDwoR: anterior disc displacement without
reduction.
* One-way ANOVA and least significant difference test for multiple comparisons; p < 0.05.

Figure 4. Graphic plot showing intensity of staining.
Notes: CO = control; CR = with reduction; NR = without reduction.

Discussion
In a healthy TMJ, the adaptive and regenerative potential of the discal tissues is sufficient to match the
destructive forces encountered during normal function. In diseased states, however, failure to maintain
homeostasis leads to initiation of an inflammatory response, which has been shown to exacerbate dysfunctional
conditions, as evidenced in TMJ-specific and more generalized osteoarthritic conditions [2,18]. Symptoms may
include clicking or popping on mandibular opening, muscle tenderness, limited mandibular opening,
intermittent locking, and headaches.
The results of this study did not reach a level of significance, as an earlier animal model study stated, showing an
increase in TLR-4 expression in TMJ dysfunction [19]. Studies have suggested that a number of endogenous
molecules may be potent activators of the innate immune system, capable of inducing proinflammatory
cytokine production and the activation of dendritic cells [19]. The results of this study showed a non-significant
trend between TLR-4 expression and level of internal derangement, from healthy to ADDwR, and finally to
ADDwoR, which would follow the proposed mechanism in severity for TMJ dysfunctional states [6,20]. TLR-4
expression may be upregulated in patients with TMJ dysfunction, and TLR-4 may, therefore, play a role in the
pathogenic inflammatory reaction, but further research is required. With a growing number of DAMPs or
“alarmins” being identified as endogenous ligands for TLR-4, it seems possible that such pathways may be

implicated in the generation of this disease. The disc is avascular, and TLR-4 may be contributing to TMD on
synovial fluids and bilaminar tissues, but by the results of this study, it would not be affecting disc degeneration
directly. Perhaps it would be altering the inflammatory process of the TMJ environment and contributing to the
complex inflammatory cascade, but not to the disc deterioration itself.
To date, no other study has evaluated expression of TLR-4 in patients with temporomandibular joint dysfunction
while using otherwise healthy patients as controls. The unique control group of this study allows for otherwise
unobtainable comparisons between the healthy and diseased states. The results of this study, therefore, have
immediate clinical relevance in understanding the pathogenesis of dysfunction states.
Several weaknesses of this study exist and should be addressed when evaluating the strength of findings. Total
sample size was small (n = 31) and may have contributed to lack of significance. Control samples were not
uniform, as half of the control samples were obtained following traumatic injuries, while the other half were
from patients with condylar hyperplasia. The interval between sample collection and processing spanned
between 8 and 15 years and may have introduced degradation of samples. Finally, evaluation of staining
required identification of fibroblasts and assessment of staining within only that portion of the sample. Samples
were assessed visually and, while blinding was present and evaluators were mostly in agreement, the evaluation
was ultimately subjective. As TLR-4 is activated in inflammatory states, the authors believe that an upregulation
characterized by increased intensity of staining within the cytoplasmic membrane is an appropriate modality for
assessment of expression. Future photographic analysis of samples may reveal TLR-4 expression levels that differ
from the assessment of the blinded evaluators used in this study.
TLR-4 has been shown to be a marker of inflammation and as a potential target for therapy [15]. Several
mediators, such as TAK-242 and MyD88 inhibitory peptide (MIP) have been shown to reduce inflammation by
acting as an antagonist to TLR-4 and MyD88 in animals, respectively [15,21]. These treatment modalities might
be incorporated into human treatments if an analogous inflammatory pathway is discovered in the pathogenesis
of TMJ dysfunction. Furthermore, animal models have shown an upregulation of TLR-4 in the TMJ complex when
occlusal interferences are experimentally introduced [19]. Current literature suggests that arthroscopic lysis and
lavage is effective in 77% of patients with early stages of TMJ dysfunction, with more severe manifestations
often requiring invasive surgical procedures [22].
A better understanding of the inflammatory pathways leading to TMJ dysfunction may allow development of
early pharmacological intervention techniques and allow for fewer patients to require open joint surgery.

Conclusion
In this study, there was no statistically significant difference between the groups with and without TMJ
dysfunction. Greater research and understanding of the inflammatory mechanisms that lead to TMJ dysfunction
is a promising route towards developing additional treatment modalities for these conditions.
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